Turning Off the ApoE4 Gene To Prevent Alzheimer’s ?!

Researchers presented a CRISPR interference (CRISPRi) technique at the March 2025 APOE conference that silences APOE4 expression in neurons without actually editing DNA. Instead of cutting and replacing genetic code, CRISPRi attaches inhibitory proteins to the APOE4 gene to block its expression. This is safer than traditional CRISPR editing because it is reversible and does not alter the underlying sequence. It is early-stage, not yet in human trials, but represents a promising future prevention avenue for APOE4 carriers.

Lipid droplets are cellular structures that store fat inside cells. In APOE4 carriers, researchers found that oligodendrocytes (the brain cells that produce myelin insulation) accumulate abnormal lipid droplets, which may be one of the earliest signs of brain dysfunction. This buildup disrupts myelin production and brain signaling long before cognitive symptoms appear. It highlights myelin and lipid handling as key targets for APOE4 prevention, especially in midlife.

GSK3-beta is an enzyme involved in multiple brain signaling pathways, including Wnt signaling which regulates lipid metabolism and myelin production. In APOE4 carriers, dysregulated GSK3-beta and impaired Wnt signaling may drive the lipid droplet buildup and myelin problems seen in oligodendrocytes. Targeting these pathways, pharmacologically or through metabolic and lifestyle approaches, could help restore healthy fat metabolism in the brain and protect the myelin insulation APOE4 carriers particularly depend on.

APOE4 alters how brain cells handle lipids, cholesterol, and energy production from early life. Lipid droplet accumulation in oligodendrocytes, mitochondrial gene shutdown in microglia, and disrupted Wnt signaling all begin long before any memory complaints emerge. This means APOE4 carriers are running a compromised metabolic program for decades silently. Prevention protocols that target these upstream metabolic and lipid problems (exercise, Mediterranean-style diet, metabolic health, DHA) intervene during the silent window when the brain is most responsive.